| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6184001 | Gynecologic Oncology | 2008 | 6 Pages |
Abstract
Both RH and definitive RT/CRT are adequate management strategies for patients with FIGO stage IB2 cervical cancer. However, there was a subset of patients in whom RH as monotherapy was appropriate. Further studies are needed to evaluate the role of new preoperative models that will accurately identify these patients.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Oliver Zivanovic, Kaled M. Alektiar, Yukio Sonoda, Qin Zhou, Alexia Iasonos, William P. Tew, John P. Diaz, Dennis S. Chi, Richard R. Barakat, Nadeem R. Abu-Rustum,